Privituss

L-Cloperastine fendizoate

Privituss

Active substance

L-Cloperastine fendizoate

Strenght and pharmaceutical forms

708 mg/100 ml oral suspension - 100ml bottle
708 mg/100 ml oral suspension - 200ml bottle

ATC

R05DB21 - cough suppressants

Therapeutic Indications

cough suppressants

Marketing Authorization Holder

Aesculapius Farmaceutici S.r.l.

Download area

Summary of Product Characteristics - Privituss – 100ml bottle

Summary of Product Characteristics - Privituss – 200ml bottle


Products of the same therapeutic areas

Events

06-07/12/2019

XVI CONGR NAZ FLEBOFORUM- XIV SIMPOSIO MALATTIA VARICOSA- VII FLEB WINTER FARM

NAPOLI

XVI CONGR NAZ FLEBOFORUM- XIV SIMPOSIO MALATTIA VARICOSA- VII FLEB WINTER FARM

 Download

08-10/11/2019

XXXII CONGRESSO NAZIONALE SNaMID

CATANIA

XXXII CONGRESSO NAZIONALE SNaMID